Characteristic | Medical | Surgical | ||
---|---|---|---|---|
No unplanned readmission | Unplanned readmission | No unplanned readmission | Unplanned readmission | |
(n = 141,840) | (n = 5583) | (n = 328,086) | (n = 11,142) | |
Vasopressor, n (%) | 26,513 (18.7) | 1136 (20.3) | 93,209 (28.4) | 3319 (29.8) |
Stress ulcer prophylaxis, n (%) | 107,214 (75.6) | 4266 (76.4) | 256,934 (78.3) | 9277 (83.3) |
Blood product usage | ||||
pRBC, n (%) | 15,930 (11.2) | 891 (16.0) | 109,216 (33.3) | 4937 (44.3) |
FFP, n (%) | 2563 (1.8) | 147 (2.6) | 23,040 (7.0) | 1006 (9.0) |
Platelets, n (%) | 4050 (2.9) | 224 (4.0) | 33,954 (10.3) | 1468 (13.2) |
Steroid use, n (%) | 5812 (4.1) | 303 (5.4) | 20,556 (6.3) | 838 (7.5) |
Anticoagulant therapy, n (%) | 86,280 (60.8) | 3296 (59.0) | 232,864 (71.0) | 8163 (73.3) |
TPN, n (%) | 36,037 (25.4) | 1574 (28.2) | 130,747 (39.9) | 4998 (44.9) |
Antibiotic usage, n (%) | 64,532 (45.5) | 2972 (53.2) | 269,500 (82.1) | 9399 (84.4) |
RRT | ||||
Number, n (%) | 9722 (6.9) | 609 (10.9) | 19,073 (5.8) | 998 (9.0) |
Duration, days, median (IQR) | 3 (2–6) | 3 (2–5) | 4 (2–6) | 3 (2–6) |
Ventilation | ||||
Number, n (%) | 27,731 (19.6) | 1459 (26.1) | 82,005 (25.0) | 3395 (30.5) |
Duration, days, median (IQR) | 4 (2–9) | 4 (2–8) | 2 (1–6) | 2 (1–6) |
Tracheostomy n (%) | 2626 (1.9) | 91 (1.6) | 8978 (2.7) | 295 (2.6) |